EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Anti-angiogenic and anti-metastatic effects of PEDF overexpression in anaplastic thyroid cancer cells: A preliminary in vitro study

Amineh Khoshnazar, Ameneh Koochaki, Sara Anajafi, Yalda Khazaei-Poul, Hossein Ghanbarian, Samira Mohammadi-Yeganeh, Mahdi Paryan, Vahid Haghpanah

Cancer Treatment and Research Communications · 2026 · 49 · 101419

DOI: 10.1016/j.ctarc.2026.101419 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Amineh Khoshnazar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shahid Beheshti University of Medical Sciences, Tehran University of Medical Sciences Endocrinology & Metabolism Research Institute, Pasteur Institute of Iran.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pigment epithelium-derived factor (PEDF) is a potent endogenous immunomodulatory protein with anti-metastatic, anti-angiogenic, and anti-inflammatory properties, and has recently gained attention for its ability to target tumor cells across various cancers. However, the molecular mechanism underlying the effects of PEDF on angiogenesis and metastasis in anaplastic thyroid cancer (ATC), one of the most lethal and aggressive human malignancies, remains poorly understood. In this study, the PEDF coding sequence was cloned into a lentiviral backbone plasmid vector, and its effects on metastasis and epithelial-to-mesenchymal transition (EMT) were assessed in 8305C ATC cells using RT-qPCR, migration, invasion, doubling time, wound healing assays, as well as western blot analysis. Angiogenesis was evaluated using the chicken chorioallantoic membrane (CAM) assay. Overexpression of PEDF in 8305C cells significantly reduced the expression of VEGF and HIF-1α, downregulated angiogenesis-related genes, and was associated with reduced expression of PI3K/AKT-related genes. Additionally, PEDF overexpression markedly decreased MMP-9 and MMP-2 levels, leading to reduced invasion, migration, and EMT-associated phenotype. These findings suggest that PEDF overexpression is associated with reduced angiogenic and metastatic phenotypes in ATC cells and warrants further investigation in additional preclinical models.

Schlagwörter

Stichwörter der Autor:innen

Anaplastic thyroid cancerAngiogenesisEMTPEDFPigment epithelium-derived factorVEGF

Autor:innen und Institutionen

  • Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Pharmacology, School of Medicine, Shahid Beheshti University…
  • Department of Molecular Medicine, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Cellular and Molecular Biology Research Center, Shahid Beheshti University…
  • Department of Research and Development, Production and Research Complex, Pasteur Institute of Iran, Tehran, Iran. Electronic address: m_paryan@pasteur.ac.ir.

Förderung

  • Shahid Beheshti University of Medical Sciences
  • Tehran University of Medical Sciences Endocrinology & Metabolism Research Institute
  • Pasteur Institute of Iran
  • Tehran University of Medical Sciences and Health Services

Zitieren

APA

Khoshnazar, A., Koochaki, A., Anajafi, S., Khazaei-Poul, Y., Ghanbarian, H., Mohammadi-Yeganeh, S., Paryan, M., & Haghpanah, V. (2026). Anti-angiogenic and anti-metastatic effects of PEDF overexpression in anaplastic thyroid cancer cells: A preliminary in vitro study. Cancer Treatment and Research Communications, 49, 101419. https://doi.org/10.1016/j.ctarc.2026.101419

Vancouver

Khoshnazar A, Koochaki A, Anajafi S, Khazaei-Poul Y, Ghanbarian H, Mohammadi-Yeganeh S, et al. Anti-angiogenic and anti-metastatic effects of PEDF overexpression in anaplastic thyroid cancer cells: A preliminary in vitro study. Cancer Treatment and Research Communications. 2026;49:101419. doi:10.1016/j.ctarc.2026.101419

BibTeX
@article{Khoshnazar2026,
  author = {Khoshnazar, Amineh and Koochaki, Ameneh and Anajafi, Sara and Khazaei-Poul, Yalda and Ghanbarian, Hossein and Mohammadi-Yeganeh, Samira and Paryan, Mahdi and Haghpanah, Vahid},
  title = {Anti-angiogenic and anti-metastatic effects of PEDF overexpression in anaplastic thyroid cancer cells: A preliminary in vitro study},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  volume = {49},
  pages = {101419},
  doi = {10.1016/j.ctarc.2026.101419}
}
Kostenlos starten →